| Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia D Drandi, E Genuardi, I Dogliotti, M Ferrante, C Jiménez, F Guerrini, ... haematologica 103 (6), 1029, 2018 | 74 | 2018 |
| Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice C Fava, G Rege-Cambrin, I Dogliotti, M Cerrano, P Berchialla, M Dragani, ... haematologica 104 (8), 1589, 2019 | 73 | 2019 |
| The choice of first-line chronic myelogenous leukemia treatment C Fava, G Rege-Cambrin, I Dogliotti, G Saglio Chronic Myeloid Leukemia, 41-54, 2016 | 37 | 2016 |
| 6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival R García‐Sanz, I Dogliotti, GM Zaccaria, EM Ocio, A Rubio, I Murillo, ... British Journal of Haematology 192 (5), 843-852, 2021 | 35 | 2021 |
| Update on emerging treatments for chronic myeloid leukemia C Fava, A Morotti, I Dogliotti, G Saglio, G Rege-Cambrin Expert Opinion on Emerging Drugs 20 (2), 183-196, 2015 | 33 | 2015 |
| New molecular technologies for minimal residual disease evaluation in B-cell lymphoid malignancies I Dogliotti, D Drandi, E Genuardi, S Ferrero Journal of Clinical Medicine 7 (9), 288, 2018 | 32 | 2018 |
| CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report I Dogliotti, C Fava, A Serra, E Gottardi, F Daraio, F Carnuccio, E Giugliano, ... Stem Cell Investigation 4, 2017 | 20 | 2017 |
| Early BCR-ABL1 reduction is predictive of better event-free survival in patients with newly diagnosed chronic myeloid leukemia treated with any tyrosine kinase inhibitor C Fava, G Rege-Cambrin, I Dogliotti, E Gottardi, P Berchialla, ... Clinical Lymphoma Myeloma and Leukemia 16, S96-S100, 2016 | 20 | 2016 |
| Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia I Dogliotti, C Jiménez, M Varettoni, D Talaulikar, T Bagratuni, M Ferrante, ... Leukemia 37 (2), 388-395, 2023 | 15 | 2023 |
| MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation M Ferrante, D Furlan, S Zibellini, M Borriero, C Candido, N Sahnane, ... Diagnostics 11 (5), 779, 2021 | 15 | 2021 |
| ABVD vs BEACOPP escalated in advanced‐stage Hodgkin’s lymphoma: Results from a multicenter European study P Mondello, C Musolino, I Dogliotti, JP Bohn, F Cavallo, S Ferrero, B Botto, ... American Journal of Hematology 95 (9), 1030-1037, 2020 | 10 | 2020 |
| Standardized IGH-based next-generation sequencing for MRD detection in follicular lymphoma C Pott, H Knecht, A Herzog, E Genuardi, M Unterhalt, B Mantoan, ... Blood 130 (Supplement 1), 1491-1491, 2017 | 10 | 2017 |
| Post-transplant lymphoproliferative disease (PTLD) after allogeneic hematopoietic stem cell transplantation: biology and treatment options M Clerico, I Dogliotti, A Aroldi, C Consoli, L Giaccone, B Bruno, F Cavallo Journal of Clinical Medicine 11 (24), 7542, 2022 | 9 | 2022 |
| Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi A Arcari, L Morello, D Vallisa, L Marcheselli, C Tecchio, FM Quaglia, ... Leukemia & Lymphoma 62 (14), 3474-3483, 2021 | 9 | 2021 |
| Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies M Varettoni, A Ferrari, AM Frustaci, VV Ferretti, R Rizzi, M Motta, F Piazza, ... American Journal of Hematology 95 (12), 1473-1478, 2020 | 9 | 2020 |
| Observational study of CML Italian patients who discontinued TKIs C Fava, G Rege-Carmbrin, I Dogliotti, M Cerrano, P Berchialla, G Rosti, ... Blood 130, 1616, 2017 | 9 | 2017 |
| Management of invasive fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation: the turin experience A Busca, N Cinatti, J Gill, R Passera, CM Dellacasa, L Giaccone, ... Frontiers in cellular and infection microbiology 11, 805514, 2022 | 8 | 2022 |
| Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. FS Genuardi E, Barbero D, Dogliotti I, Mantoan B, Drandi D, Gambella M ... Int J Lab Hematol., 2017 | 8* | 2017 |
| Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma E Genuardi, P Klous, B Mantoan, D Drandi, M Ferrante, F Cavallo, ... Hematological Oncology 39 (3), 293-303, 2021 | 6 | 2021 |
| Real life use of bendamustine in elderly patients with lymphoid neoplasia I Dogliotti, S Ragaini, F Vassallo, E Boccellato, G De Luca, F Perutelli, ... Journal of Personalized Medicine 11 (4), 249, 2021 | 6 | 2021 |
Mario BoccadoroEmeritus Professor of Hematology, University of Torino, ItalyVerified email at unito.it
